CoChat

Effects of the route of oestrogen administration on IGF‐1 and IGFBP‐3 in healthy postmenopausal women: results from a randomized placebo‐controlled study

Sonnet, Emmanuel, Lacut, Karine, Roudaut, Nathalie, Mottier, Dominique, Kerlan, Véronique, Oger, Emmanuel · 2007 · Clinical Endocrinology
Cited by 44

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Objective Oestrogens can modulate the action or secretion of GH. Previous studies in postmenopausal women have shown a differential effect between transdermal 17β‐oestradiol and oral ethynyl‐oestradiol on GH and IGF‐1 concentrations. This secondary analysis, based on a large randomized trial, aimed to estimate the effect of the route of administration of 17β‐oestradiol in combined hormone replacement therapy with progesterone on IGF‐1 and IGFBP‐3 levels. Design IGF‐1 and IGFBP‐3 were evaluated in a randomized study of 196 healthy postmenopausal women who were randomly allocated to receive on a continuous basis either 1 mg of 17β‐oestradiol orally combined with a daily intake of 100 mg progesterone (group 1; n = 63), or 50 µg of 17β‐oestradiol transdermally combined with a daily intake of 100 mg progesterone (group 2; n = 68), or triple dummy placebo (group 3; n = 65) over a 6‐month period. IGF1 and IGFBP‐3 levels were available for 133 women. Results Oral oestrogen significantly decreased IGF‐1 levels compared to placebo (P = 0·04) and transdermal oestrogen (P = 0·004), whereas transdermal oestrogen had no effect on IGF‐1 levels compared to placebo (P = 0·56). As regards IGFBP‐3, no significant difference was detected between the three groups. Conclusions Our data indicate that the route of oestrogen administration can influence IGF‐1 levels. IGF‐1 concentrations decreased significantly with oral oestrogen, whereas no significant change was observed with transdermal oestrogen at 6 months. The clinical relevance of these differential effects remains to be determined, particularly with regard to the risk for cardiovascular diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2007.02783.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 44

Metadata

Authors
Sonnet, E., Lacut, K., Roudaut, N., Mottier, D., Kerlan, V., & Oger, E.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2007-02-26
Volume
66
Issue
5
Pages
626-631
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2060221405
Cited by
44
References
6
FWCI
2.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.